ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Pediatric Pulmonology
Volume 13 - 2025 | doi: 10.3389/fped.2025.1482880
This article is part of the Research TopicPulmonary infection in childrenView all 5 articles
Co-detection of respiratory pathogens in children with Mycoplasma pneumoniae pneumonia: A multicenter study
Provisionally accepted- 1Shanghai Children's Hospital, Shanghai, China
- 2Tianjin Children's Hospital, Tianjin, China
- 3West China Second University Hospital, Sichuan University, Chengdu, Sichuan Province, China
- 4Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China
- 5Ya'an People’s Hospital, Yaan, Sichuan Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: To investigate the prevalence and clinical significance of respiratory pathogen co-detection in children diagnosed with Mycoplasma pneumoniae pneumonia (MPP). Methods: A prospective observational multicenter study was conducted, collecting clinical data from pediatric patients diagnosed with MPP in four hospitals across China from December 1 to December 31, 2023. Targeted next-generation sequencing (tNGS) results and clinical characteristics were analyzed. Participants were divided into mild and severe groups according to disease severity. Severe cases were further subdivided into an MP alone group and a multi-pathogen co-detection group. Receiver operating characteristic (ROC) curve analysis was performed to assess the predictive performance of inflammatory biomarkers for multi-pathogen co-detection.Results: A total of 266 children were enrolled. Severe cases had significantly higher C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), lactate dehydrogenase (LDH), D-dimer, interleukin-6 (IL-6), IL-10, and interferon-γ (IFN-γ) levels, as well as longer hospital stays (all P < 0.05). Multi-pathogen co-detection was found in 49.62% of MPP patients, and was more frequent in severe cases than in mild cases (54.05% vs. 39.51%, P < 0.05). The most common co-detected pathogens were rhinovirus, adenovirus, influenza A virus, Haemophilus influenzae, and Streptococcus pneumoniae. Among severe cases, the white blood cell (WBC) count and LDH, IL-6, and IL-10 levels were significantly higher in the multi-pathogen co-detection group compared to the MP alone group (P < 0.05).ROC analysis revealed that IL-6 and IL-10, especially in combination, effectively predicted multi-pathogen co-detection.Conclusions: Multi-pathogen co-infections substantially influence the severity of pediatric MPP. The findings highlight the diagnostic value of tNGS for identifying co-pathogens and underscore the predictive potential of inflammatory biomarkers (especially IL-6 and IL-10). The integration of tNGS and these biomarkers may facilitate early detection and targeted therapeutic interventions, thereby improving prevention and treatment outcomes in pediatric MPP.
Keywords: Mycoplasma pneumoniae, Child, Pneumonia, Pathogen co-detection rate, Targeted next-generation sequencing
Received: 18 Aug 2024; Accepted: 29 Apr 2025.
Copyright: © 2025 Dong, Li, YINGXUE, Chen, Zhang, Lv, Yang, Yanhua, Wang, Guo, Wang, Li, Lin, Luo, Lu, Lu and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Quan Lu, Shanghai Children's Hospital, Shanghai, China
Hanmin Liu, West China Second University Hospital, Sichuan University, Chengdu, 610041, Sichuan Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.